Westwood Holdings Group’s CareDx CDNA Stock Holding History

Westwood Holdings Group’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-30,071	Closed	-$646K	–	452
2022 Q2	$646K	Buy	+30,071	New	+$834K	0.01%	379

Other funds holding CDNA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Westwood Holdings Group's CDNA Position: Q3 2022 in Review

Westwood Holdings Group sold out of CareDx (CDNA) in Q3 2022, closing a stake of 30,071 shares — an estimated $646K sold.

Westwood Holdings Group first reported a position in CDNA in Q2 2022 and held it in 1 quarter. The position peaked at $646K in Q2 2022. 182 funds tracked by Wall St. Rank hold CDNA as of Q3 2022.

Westwood Holdings Group reported no remaining CareDx position as of Q3 2022 after selling out during the quarter.
Westwood Holdings Group sold 30,071 CareDx shares in Q3 2022, an estimated $646K.
Westwood Holdings Group first reported a position in CareDx in Q2 2022 and held it in 1 quarter.
Westwood Holdings Group's CareDx position peaked at $646K in Q2 2022.
182 funds tracked by Wall St. Rank held CareDx as of Q3 2022.

Based on Westwood Holdings Group's 13F filing for Q3 2022, filed 14 Nov 2022.